P. Friscia

Results of a phase I/II trial of carboplatin/gemcitabine plus celecoxib for first-line treatment of stage IIIB/IV non-small cell lung cancer (NSCLC)

J. Burton, F. Forte, M. Bhargava, 2005 .

Update of a phase I/II trial of carboplatin/gemcitabine plus escalating doses of celecoxib for first-line treatment of stage IIIB/IV non-small cell lung cancer (NSCLC)

J. Burton, F. Forte, T. Terjanian, 2004 .

Stereotactic body radiation therapy for nonmetastatic lung cancer: an analysis of 75 patients treated over 5 years.

J. Beitler, T. Terjanian, P. Silverman, 2006, International journal of radiation oncology, biology, physics.

Update of a phase I/II trial of carboplatin/gemcitabine plus escalating doses of celecoxib for first-line treatment of stage IIIB/IV non-small cell lung cancer (NSCLC).

J. Burton, F. Forte, T. Terjanian, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.